X
Logo IZB Innovations- und Gründerzentrum Biotechnologie
IZB Signet

Events at the IZB

Where the biotech community meets

Through its regular events, IZB brings together players from biotechnology, life sciences, academia and the investment community at the Martinsried campus.

From informal networking at the Happy Hour and current biotech topics at the IZBrunch to practical legal know-how at the Law Lab and exchanges between life science projects and investors at the Munich Life Science Pitch Day – IZB events create opportunities for connection, knowledge sharing and new contacts.

Find all upcoming events in our event calendar. Registration is required for selected events.

Event Calendar

Campus and biotech community events at a glance

  • “At IZB, we connect with a unique network of pharmaceutical companies, research institutions, and investors – an ideal ecosystem to drive our biotechnology forward.”
    Dr. Luitpold Fried, Managing Director
  • “The IZB provides our team the perfect environment to kick-start our projects and operations and we are grateful to be part of this community.”
    Dr. Adrian Schomburg, CEO & Founder Eisbach Bio GmbH
  • “The IZB is a lighthouse for innovation. ... The provided space is essential for successfully implementing our pioneering ideas and leaving a lasting impact. ...”
    Dr. Patrick Großmann und Dr. Kilian Vogele, Invitris, managing directors
  • “Since the time we moved to the IZB, our headcount grew steadily from 6 to 60 employees. The IZB supported us continuously and we look forward to being part of the IZB in future.”
    Michael Scholl, CEO
  • “As part of the IZB family we have access ­to a great location and an excellent start-up network.”
    Dr. Garwin Pichler, CEO, Dr. Nils Kulak, CEO, PreOmics GmbH


  • “We are pleased to be part of the IZB family, a leading innovation center in Europe and are looking forward to building a strong research team with local talent and connecting our global team to the renowned scientific community of Munich.”
    Dr. Karin Wisskirchen, Managing Director & Head of Research, Dr. Susanne Wilde, Head of Preclinical Research und Dr. Gregory Fanning, Acting-CEO SCG Cell Therapy GmbH
  • “The IZB provides our team with a valuable infrastructure and network that is conducive to our goal of opening new avenues for the treatment of solid tumors and bringing safe and effective ADCs to patients.”
    Dr. Dominik Schumacher, Dr. Jonas Helma-Smets, Tubulis
Event-Anmeldung

*Ja, ich habe die Datenschutzerklärung zur Kenntnis genommen und bin damit einverstanden, dass die von mir angegebenen Daten elektronisch erhoben und gespeichert werden. Meine Daten werden dabei nur streng zweckgebunden zur Bearbeitung und Beantwortung meiner Anfrage benutzt. Mit dem Absenden des Kontaktformulars erkläre ich mich mit der Verarbeitung einverstanden. / I have taken note of the Privacy policy and I agree that the data I have provided will be collected and stored electronically. My data is used only strictly for the processing and answering of my request. By submitting the contact form, I agree to the processing.

menuchevron-down